Profile Picture
Rewards
  • All
  • Chat
  • Images
  • News
  • More
    • Videos
    • Maps
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business
  • interests

Trending on Bing

Announces new album
A happy meal for Trump
Breeding mill busted
‘Political stunt’
Crash kills 6 girls
To use bottled water?
Anti-gravity treadmill
Invited to see 'David'
'Wish I knew about it'
Beef product recalled
Animal exploitation
Kicks off Africa trip
Israel mass protests
Durbin endorses Vallas
Burns wins Match Play
Test-fires 2 missiles
Source code leaked
1st trip to Final Four
US Army ads pulled
LeBron James returns
Moving ahead with bill
Fires defense minister
12 injured at party
NATO criticizes Putin
Pardons Israeli woman
Plans concert film
A civilian government?
Holm dominates Santos
UKR demands UN meeting
Blast in Russian town
Tang's amazing speech
Two tigers recaptured
Diagnosed with cancer
Museum of Failure
Inks deal to buy SVB
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
1,110 results
Yahoo1mon
Danaher Shows Interest In Acquiring Catalent Valued At Significant Premium: Report
It's unclear how Catalent will proceed or whether it's receptive to a takeover offer, Bloomberg reported citing people familiar with the matter. Danaher and Catalent deal could be one of the ...
Nasdaq1mon
Danaher interested in buying life sciences firm Catalent- Bloomberg News
Danaher's approach to Catalent values it at a significant premium, the report said, adding that unclear how Catalent will proceed or whether it is receptive to a takeover offer. A deal is not ...
Forbes16d
What’s Next For Catalent Stock After A 50% Rise This Year?
UKRAINE - 2021/05/04: In this Photo illustration a Catalent logo of a pharmaceutical company is seen ... [+] on a smartphone and a pc screen. (Photo Illustration by Pavlo Gonchar/SOPA Images ...
Yahoo Finance3d
Here's Why You Should Retain Catalent (CTLT) Stock for Now
Catalent, Inc. CTLT is well-poised for growth in the coming quarters, courtesy of its product and service launches over the past few months. The optimism led by a solid second-quarter fiscal 2023 ...
Yahoo News Australia1mon
Danaher Takes Interest in Life Sciences Firm Catalent
(Bloomberg) -- Life sciences company Danaher Corp. has expressed takeover interest in contract manufacturer Catalent Inc., according to people familiar with the matter. Most Read from Bloomberg ...
TheStreet.com2d
Danaher (DHR) Stock Soaring on Pall Corp. Acquisition, Split Announcements
Danaher (DHR) stock is rising after the company announced it will acquire Pall Corp. (PLL) and split itself into two companies. Danaher (DHR) stock is rising after the company announced it will ...
MD&M East4d
Why Danaher Plans to Split Up
Danaher Corp. will split into two companies on July 2, completing the separation into two two independent, publicly traded ventures that it announced in May 2015. The split will free the two entities ...
TheStreet.com10d
Pall Corp. (PLL) Stock Jumping on $13.8 Billion Danaher Takeover
Pall Corp. (PLL) stock is rising after the company said it will be acquired by Danaher (DHR) for $13.8 billion. Pall Corp. (PLL) stock is rising after the company said it will be acquired by ...
Seeking Alpha21d
Danaher: Compounder Starts To Look Attractive
Danaher made a huge move when it acquired the biopharma activities of GE (GE) in 2019 in a $21 billion deal, adding more than $3 billion in very profitable sales to its line-up of the business ...
Yahoo Finance1mon
Catalent (CTLT) Surges on Rumors of Acquisition by Danaher
Shares of Catalent CTLT gained 19.5% on Monday on rumors of a potential acquisition by a life sciences company — Danaher DHR. The CTLT stock started its upward journey during pre-market trading on Feb ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback